Found 441 articles for: "General Medical Dermatology"
Off-Label Uses of Nemolizumab: A Narrative Review
October 2026 | Volume 25 | Issue 10 | Original Article | 956 | Copyright © October 2026
Background: Nemolizumab, a humanized monoclonal antibody targeting interleukin-31 receptor α (IL-31Rα), is approved for atopic dermatitis (AD) and prurigo nodularis (...
Read MoreA Narrative Review of Seven Off-Label Treatment Options for Seborrheic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 943 | Copyright © October 2026
Background: Seborrheic dermatitis (SD) is a chronic inflammatory skin condition driven by overactive sebaceous glands, Malassezia colonization, immune dysfunction, and epidermal ...
Read MoreAssociation Between Sodium-Glucose Cotransporter-2 Inhibitors and Vulvar Pruritus Without Vulvovaginal Candidiasis: A TriNetX-Based Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e89 | Copyright © October 2026
Cardamonin Inhibits Keloid Fibroblast Activation and Extracellular Matrix Production Through Suppression of TGF-β1/Smad Signaling
September 2026 | Volume 25 | Issue 9 | Original Article | 857 | Copyright © September 2026
Background: Keloids are pathological scars characterized by persistent fibroblast activation and excessive extracellular matrix (ECM) deposition. Cardamonin (CARD), a natural cha...
Read MoreJAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic Scars: A Multi-Center Retrospective Cohort Study
September 2026 | Volume 25 | Issue 9 | Original Article | 779 | Copyright © September 2026
Background: Keloids and hypertrophic scars are fibroproliferative skin disorders characterized by excessive collagen deposition and high recurrence rates despite existing therapi...
Read MoreEyebrow Madarosis: An Updated Review of the Etiology and Management, Part II– Scarring Disorders
September 2026 | Volume 25 | Issue 9 | Original Article | 852 | Copyright © September 2026
Background: Eyebrows play an essential role in facial symmetry, communication, and aesthetic identity. Scarring eyebrow alopecia results from inflammatory, autoimmune, infectious...
Read MoreGLP-1 Receptor Agonist Paradox in Hair Biology: A Biphasic dWAT–Follicle Signaling Hypothesis
September 2026 | Volume 25 | Issue 9 | Features | 874 | Copyright © September 2026
Systemic Corticosteroids in the Perioperative Setting for Prevention of Pyoderma Gangrenosum During Reconstructive Surgery
September 2026 | Volume 25 | Issue 9 | Case Reports | 865 | Copyright © September 2026
Pyoderma gangrenosum (PG) is classified as a neutrophilic dermatosis, often presenting as a rapidly enlarging ulcer and associated with inflammatory bowel disease, specifically ulcerative colitis...
Read MoreTopical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report
September 2026 | Volume 25 | Issue 9 | Case Reports | 868 | Copyright © September 2026
Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder characterized by persistent, violaceous, reticulated skin changes that may be complicated by painful ulcera...
Read MoreReview of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia
September 2026 | Volume 25 | Issue 9 | Features | 871 | Copyright © September 2026
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
August 2026 | Volume 25 | Issue 8 | Original Article | 701 | Copyright © August 2026
Background: Papulopustular rosacea (PPR) is a chronic inflammatory facial dermatosis with a need for well-tolerated and effective topical therapies. Clascoterone cream 1% is an a...
Read MoreMolluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
August 2026 | Volume 25 | Issue 8 | Original Article | 717 | Copyright © August 2026
Background: Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substa...
Read MoreImprovement of Rosacea With Tirzepatide: A Case Report
August 2026 | Volume 25 | Issue 8 | Case Reports | 749 | Copyright © August 2026
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum
August 2026 | Volume 25 | Issue 8 | Features | e71 | Copyright © August 2026
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape
August 2026 | Volume 25 | Issue 8 | Features | 765 | Copyright © August 2026
Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients
July 2026 | Volume 25 | Issue 7 | Original Article | 621 | Copyright © July 2026
Background: Anticancer treatments are associated with cutaneous adverse events (cAEs) that can severely impact patients' quality of life (QoL) and interfere with treatment outcom...
Read MoreDecoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America
July 2026 | Volume 25 | Issue 7 | Original Article | 632 | Copyright © July 2026
Background: Sensitive skin syndrome (SSS) is a common self-reported condition, more prevalent in women, characterized by redness, irritation, and discomfort in response to variou...
Read MoreMyo-Inositol in Pregnancy: Implications for Acne Management
July 2026 | Volume 25 | Issue 7 | Original Article | 611 | Copyright © July 2026
Background: Acne vulgaris is common during pregnancy and presents unique therapeutic challenges due to fetal safety considerations and restrictions on conventional acne medicatio...
Read MoreCutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
July 2026 | Volume 25 | Issue 7 | Case Reports | 659 | Copyright © July 2026
Background: Aromatase inhibitors (AIs) and anti-HER2 therapies improve breast cancer survival, but dermatologic adverse events (dAEs) are underrecognized despite affecting qualit...
Read MoreAlopecia Areata in Children and the Emerging Role of JAK Inhibitors
July 2026 | Volume 25 | Issue 7 | Features | e61 | Copyright © July 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
